Delayed
Nasdaq Stockholm
06:31:11 29/04/2024 pm IST
|
5-day change
|
1st Jan Change
|
1.595
SEK
|
+3.57%
|
|
-6.73%
|
-26.83%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Capitalization
1 |
223
|
472.4
|
453.7
|
569.9
|
361.5
|
108.5
|
108.5
|
-
|
Enterprise Value (EV)
1 |
223
|
460.4
|
453.7
|
579
|
370.9
|
166.7
|
111.7
|
108.5
|
P/E ratio
|
-
|
-11.3
x
|
-8.58
x
|
-13.3
x
|
-15.1
x
|
-8.72
x
|
-
|
5.13
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
6.61
x
|
11.6
x
|
-
|
9.99
x
|
4.95
x
|
1.79
x
|
0.91
x
|
0.62
x
|
EV / Revenue
|
6.61
x
|
11.3
x
|
-
|
10.1
x
|
5.08
x
|
1.94
x
|
0.93
x
|
0.62
x
|
EV / EBITDA
|
-
|
-17.5
x
|
-
|
-20.1
x
|
-54.4
x
|
1,938
x
|
7.21
x
|
2.58
x
|
EV / FCF
|
-
|
-9.97
x
|
-
|
-10.6
x
|
-17.4
x
|
-16.1
x
|
6.21
x
|
3.88
x
|
FCF Yield
|
-
|
-10%
|
-
|
-9.4%
|
-5.74%
|
-6.2%
|
16.1%
|
25.8%
|
Price to Book
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Nbr of stocks (in thousands)
|
40,548
|
55,059
|
55,059
|
65,059
|
70,474
|
70,474
|
70,474
|
-
|
Reference price
2 |
5.500
|
8.580
|
8.240
|
8.760
|
5.130
|
1.540
|
1.540
|
1.540
|
Announcement Date
|
26/02/19
|
25/02/20
|
18/02/21
|
17/02/22
|
16/02/23
|
15/02/24
|
-
|
-
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net sales
1 |
33.74
|
40.7
|
-
|
57.07
|
73
|
86.06
|
119.8
|
174
|
EBITDA
1 |
-
|
-26.26
|
-
|
-28.82
|
-6.815
|
0.086
|
15.5
|
42
|
EBIT
1 |
-
|
-36.53
|
-
|
-41.55
|
-20.61
|
-15.03
|
-0.1
|
26
|
Operating Margin
|
-
|
-89.75%
|
-
|
-72.81%
|
-28.24%
|
-17.46%
|
-0.08%
|
14.94%
|
Earnings before Tax (EBT)
1 |
-
|
-37.95
|
-
|
-43.08
|
-22.4
|
-17.23
|
3
|
26
|
Net income
1 |
-
|
-38.04
|
-52.96
|
-43.09
|
-22.41
|
-17.36
|
3
|
21
|
Net margin
|
-
|
-93.45%
|
-
|
-75.49%
|
-30.7%
|
-20.17%
|
2.5%
|
12.07%
|
EPS
2 |
-
|
-0.7600
|
-0.9600
|
-0.6600
|
-0.3400
|
-0.2500
|
-
|
0.3000
|
Free Cash Flow
1 |
-
|
-46.19
|
-
|
-54.43
|
-21.29
|
-10.34
|
18
|
28
|
FCF margin
|
-
|
-113.48%
|
-
|
-95.37%
|
-29.17%
|
-12.02%
|
15.03%
|
16.09%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
116.13%
|
66.67%
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
600%
|
133.33%
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
26/02/19
|
25/02/20
|
18/02/21
|
17/02/22
|
16/02/23
|
15/02/24
|
-
|
-
|
Fiscal Period: December |
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
---|
Net sales
1 |
21.6
|
21.09
|
22.22
|
21.27
|
EBITDA
1 |
0.184
|
-0.91
|
0.674
|
0.138
|
EBIT
1 |
-3.498
|
-4.657
|
-3.154
|
-3.717
|
Operating Margin
|
-16.19%
|
-22.08%
|
-14.2%
|
-17.48%
|
Earnings before Tax (EBT)
|
-
|
-
|
-
|
-
|
Net income
|
-
|
-
|
-
|
-
|
Net margin
|
-
|
-
|
-
|
-
|
EPS
2 |
-0.0600
|
-0.0700
|
-0.0500
|
-0.0700
|
Dividend per Share
|
-
|
-
|
-
|
-
|
Announcement Date
|
25/05/23
|
17/08/23
|
16/11/23
|
15/02/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net Debt
1 |
-
|
-
|
-
|
9.09
|
9.4
|
13.1
|
3.2
|
-
|
Net Cash position
1 |
-
|
12
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-0.3154
x
|
-1.379
x
|
152.1
x
|
0.2065
x
|
-
|
Free Cash Flow
1 |
-
|
-46.2
|
-
|
-54.4
|
-21.3
|
-10.3
|
18
|
28
|
ROE (net income / shareholders' equity)
|
-
|
-69.1%
|
-
|
-79.2%
|
-80.9%
|
-110%
|
30%
|
100%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
1 |
-
|
21.3
|
-
|
10.6
|
2.72
|
4.6
|
4
|
6
|
Capex / Sales
|
-
|
52.33%
|
-
|
18.5%
|
3.72%
|
5.34%
|
3.34%
|
3.45%
|
Announcement Date
|
26/02/19
|
25/02/20
|
18/02/21
|
17/02/22
|
16/02/23
|
15/02/24
|
-
|
-
|
|
1st Jan change
|
Capi.
|
---|
| -26.83% | 9.9M | | +73.17% | 12.38B | | -18.74% | 7.92B | | +16.15% | 7.2B | | +6.69% | 5.84B | | +5.99% | 5.07B | | +27.07% | 4.53B | | -21.67% | 3.88B | | -40.82% | 2.23B | | +0.99% | 2.02B |
Medical Equipment
|